Izote Biosciences

What Izote Biosciences does

Izote Biosciences is a Berkeley, California-based fermentation technology company founded in 2022 that has built an anaerobic biomanufacturing platform for industrial-scale production of small molecules and proteins. The platform's core innovation is the use of proprietary oxygen-independent microbial hosts combined with an alternative molecule that is 100,000 times more soluble than oxygen, which dissolves directly into the cell media and removes the need for traditional tank aeration equipment such as air compressors, blowers, and agitators. The company claims this architecture delivers up to 30% OPEX reduction, 70% energy reduction, and 50% CAPEX reduction versus conventional fermentation, while enabling low-cost bioreactors, extended fermentation runs, and predictable lab-to-commercial scaling.

The company serves the fragrance, pharmaceutical, and specialty chemical industries through a direct B2B enterprise sales motion, with collaboration and partnership inquiries handled via a 'Get in touch' form on its corporate website. Pricing is not publicly disclosed, and the revenue model is described as fermentation manufacturing services rather than technology licensing. As of the most recent disclosures, Izote has raised a cumulative $5.7M across two funding rounds — a $2.6M seed in February 2024 and a $3.1M round in February 2025 co-led by EGB Capital and Embark Ventures — with ten disclosed venture investors backing the company. The team is reported at 1-10 employees, with Victor Reyes-Umana named as Chief Executive Officer.

Name

Izote Biosciences

Legal name

Izote

Website

https://Izote.bio

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

Izote Biosciences is a Berkeley-based fermentation technology company founded in 2022 that uses proprietary oxygen-independent microbial hosts and an anaerobic platform to manufacture small molecules and proteins for the fragrance, pharmaceutical, and specialty chemical industries, eliminating the need for traditional aeration equipment.

Ownership category

akta.pro rank

Product category

Industrial Biomanufacturing

NAICS

Chemical Manufacturing (325)

SIC

Industrial Organic Chemicals (2860)

akta.pro primary industry

Bio-based Solvents & Process Chemicals (e.g., bio-acetone, bio-butanol, bio-IPA, green solvents) (EUAAAIAB)

Keywords

• Anaerobic fermentation
• Industrial biomanufacturing
• Specialty chemicals manufacturing
• Pharmaceutical fermentation
• Fragrance ingredients production

Headquarters

HQ city

Berkeley

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Fermentation manufacturing services: Manufacturing high-performance small molecules and proteins for industrial clients in fragrance, pharmaceutical, and specialty chemical industries using proprietary anaerobic fermentation technology

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Izote Biosciences operates a proprietary anaerobic fermentation platform that uses oxygen-independent microbial hosts to manufacture high-performance small molecules and proteins. The platform replaces traditional tank aeration with an alternative molecule that is 100,000x more soluble than oxygen, eliminating the need for air compressors, blowers, and agitators. The company produces ingredients for the fragrance, pharmaceutical, and specialty chemical industries.

Product overview

Izote Biosciences offers a single unified fermentation technology platform centered on their proprietary anaerobic microbial hosts. The core platform enables industrial biomanufacturing of small molecules and proteins without oxygen, using an alternative molecule that is 100,000x more soluble than oxygen. This eliminates conventional tank aeration infrastructure (air compressors, blowers, agitators), enabling highly predictable scaling, extended fermentation runs, and low-cost bioreactors. The company manufactures products for the fragrance, pharmaceutical, and specialty chemical industries.

Differentiator

Problem solved

Functional benefit

Products and services

• Anaerobic Fermentation Platform Industrial biomanufacturing platform using proprietary anaerobic microbial hosts that enable oxygen-independent fermentation, removing the need for tank aeration via air compressors, blowers, and agitators. Delivers up to 30% OPEX reduction, 70% energy reduction, and 50% CAPEX reduction for enterprise customers in fragrance, pharmaceutical, and specialty chemical industries.

Quantifiable outcome

• 30% reduction in OPEX
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators4 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Ginkgo Bioworks: Ginkgo Bioworks is a synthetic biology platform that engineers microorganisms and offers biomanufacturing services across pharmaceuticals, specialty chemicals, and industrial applications — directly analogous to Izote's fermentation platform and end-market focus.
• Culture Biosciences: Culture Biosciences is a fermentation Contract Development & Manufacturing Organization (CDMO) offering bioreactor-based services for industrial biotechnology customers — closely matching Izote's manufacturing-services model and target customer profile.
• LanzaTech: LanzaTech uses proprietary anaerobic gas-fermenting microbes to produce sustainable fuels and chemicals from industrial waste gases. Its anaerobic organism engineering and chemical-from-fermentation model is the closest technical analog to Izote's approach.
• Antheia: Antheia uses synthetic biology and fermentation to manufacture critical pharmaceutical alkaloid intermediates that are otherwise extracted from plants. It directly competes with Izote in fermentation-based production of pharmaceutical small molecules.
• Conagen: Conagen is a synthetic biology company that develops engineered microbes for fermented production of ingredients used in food, flavor, fragrance, and specialty chemicals — overlapping heavily with Izote's fermentation platform and customer segments.
• Codexis: Codexis engineers enzymes and microbial strains for pharmaceutical and fine chemical manufacturing, including biocatalytic and fermentation-based production — a direct comparator in organism-based specialty chemical production.
• Bota Bio: Bota Bio is a synthetic biology platform that develops engineered microorganisms for industrial fermentation of chemicals, materials, and consumer products. Its platform architecture and end-market focus closely mirror Izote's offering.

Broad incumbents

• Amyris: Amyris pioneered fermentation-based production of specialty ingredients for cosmetics, fragrances, and flavors. Though it has restructured, it remains a reference point for fermentation-derived specialty chemicals and demonstrates both the opportunity and execution risks in the space.
• Novonesis: Novonesis (formed from the Novozymes-Chr. Hansen merger) is the global leader in industrial enzymes and microbial fermentation platforms serving food, pharma, and industrial customers — a broad incumbent whose capabilities overlap with Izote's fermentation services.

Emerging players

• Carbios: Carbios develops enzyme-based bioprocesses for plastic and textile recycling, but its core competency in deploying engineered biological systems for industrial chemical transformation shares methodological commonality with Izote's fermentation platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/izote-bio

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Izote Biosciences